Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech enters collaboration with Myeloma UK and Celgene

March 16 (Reuters) - Oncolytics Biotech Inc  ONC.TO  
    * Oncolytics biotech enters into first-in-class 
collaboration with Myeloma UK and Celgene using Reolysin in 
combination with Imnovid or Revlimid in patients with Myeloma 
    * Phase 1b trial will study immuno-viral therapy, Reolysin 
in combination with Celgene Corporation's immunomodulatory drugs 
 
Source text for Eikon:  ID:nPn7hyg68a  
Further company coverage:  ONC.TO  
 
 (Bangalore.newsroom@thomsonreuters.com)

Recent news on Oncolytics Biotech

See all news